Technology
Health
Pharmaceutical

Adial Pharmaceuticals

$2.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.44%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ADIL and other stocks, options, ETFs, and crypto commission-free!

About

Adial Pharmaceuticals, Inc Common Stock, also called Adial Pharmaceuticals, is focused on the treatment of alcohol use disorder. Its lead product AD04, a selective serotonin-3 antagonist is in Phase 3 clinical trial. Read More The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.

Employees
Headquarters
Charlottesville, Virginia
Founded
2010
Market Cap
22.98M
Price-Earnings Ratio
Dividend Yield
Average Volume
656.33K
High Today
$2.27
Low Today
$2.20
Open Price
$2.22
Volume
25.69K
52 Week High
$9.44
52 Week Low
$1.11

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Alcohol
Beverages
Food

Earnings

-$1.48
-$1.04
-$0.61
-$0.17
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.17 per share
Actual
Expected May 28, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.